Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

NEW
NYSE:BMY (USA)   Ordinary Shares
$ 63.63 -2.26 (-3.43%) 12:39 PM EST
14.02
P/B:
5.82
Market Cap:
$ 129.98B
Enterprise V:
$ 163.96B
Volume:
6.80M
Avg Vol (2M):
12.73M
Trade In:
Volume:
6.80M
Avg Vol (2M):
12.73M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for BMY ( Bristol-Myers Squibb Co ) from 1990 to Aug 05 2026. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Bristol-Myers Squibb stock (BMY) PE ratio as of Aug 05 2026 is 14.02. More Details

Bristol-Myers Squibb Co (BMY) PE Ratio (TTM) Chart

To

Bristol-Myers Squibb Co (BMY) PE Ratio (TTM) Historical Data

Total 1218
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Bristol-Myers Squibb PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2026-08-05 14.3 14.41 13.93 14.06 2026-06-01 16.1 16.14 15.37 15.44
2026-08-04 14.3 14.61 14.07 14.51 2026-05-29 16.0 16.1 15.88 16.06
2026-08-03 14.6 15 14.13 14.42 2026-05-28 16.2 16.21 15.8 15.99
2026-07-31 14.3 14.46 13.99 14.39 2026-05-27 16.3 16.52 16.05 16.16
2026-07-30 13.8 14.44 13.71 14.29 2026-05-26 16.8 16.79 16.3 16.3
2026-07-29 14.1 14.08 13.9 13.9 2026-05-22 16.9 16.92 16.64 16.7
2026-07-28 14.0 14.31 13.92 14.01 2026-05-21 16.4 16.74 16.24 16.73
2026-07-27 13.7 13.97 13.71 13.78 2026-05-20 16.5 16.63 16.32 16.44
2026-07-24 13.6 13.84 13.57 13.68 2026-05-19 16.1 16.47 16.03 16.38
2026-07-23 13.4 13.67 13.31 13.55 2026-05-18 16.1 16.43 16.03 16.1
2026-07-22 13.5 13.59 13.34 13.38 2026-05-15 15.9 16.04 15.77 16.01
2026-07-21 13.2 13.44 13.17 13.42 2026-05-14 15.9 16.02 15.76 15.95
2026-07-20 13.4 13.51 13.22 13.25 2026-05-13 15.7 15.96 15.69 15.84
2026-07-17 13.4 13.72 13.32 13.38 2026-05-12 15.7 16.02 15.58 15.86
2026-07-16 12.9 13.34 12.9 13.33 2026-05-11 15.8 15.87 15.56 15.64
2026-07-15 12.6 13.04 12.56 12.93 2026-05-08 15.8 15.88 15.67 15.78
2026-07-14 13.0 13.03 12.51 12.54 2026-05-07 15.8 15.98 15.61 15.8
2026-07-13 12.8 13.09 12.67 13.07 2026-05-06 16.1 16.12 15.83 15.9
2026-07-10 12.7 12.76 12.54 12.68 2026-05-05 16.0 16.15 15.94 16
2026-07-09 12.7 12.78 12.59 12.76 2026-05-04 16.2 16.29 15.99 16.12
2026-07-08 12.8 12.82 12.63 12.67 2026-05-01 16.9 16.88 16.3 16.35
2026-07-07 12.7 12.88 12.65 12.77 2026-04-30 16.2 17.07 16.12 17.02
2026-07-06 12.7 12.8 12.44 12.49 2026-04-29 16.2 16.4 16.09 16.18
2026-07-02 12.5 12.81 12.43 12.8 2026-04-28 16.5 16.5 16.27 16.37
2026-07-01 12.7 12.71 12.4 12.43 2026-04-27 16.4 16.61 16.21 16.23
2026-06-30 12.9 12.97 12.61 12.69 2026-04-24 16.5 16.63 16.39 16.49
2026-06-29 12.7 12.9 12.59 12.9 2026-04-23 16.5 16.64 16.47 16.58
2026-06-26 15.6 16.22 15.56 16.16 2026-04-22 16.7 16.77 16.48 16.52
2026-06-25 15.6 15.78 15.46 15.56 2026-04-21 16.6 16.78 16.23 16.68
2026-06-24 15.7 15.9 15.39 15.45 2026-04-20 16.9 16.89 16.55 16.61
2026-06-23 15.6 15.71 15.44 15.6 2026-04-17 16.6 16.99 16.44 16.9
2026-06-22 15.2 15.37 15.17 15.37 2026-04-16 16.2 16.57 16.2 16.56
2026-06-18 15.5 15.54 15.01 15.17 2026-04-15 16.3 16.34 16.07 16.26
2026-06-17 15.7 15.79 15.45 15.53 2026-04-14 16.3 16.47 16.17 16.31
2026-06-16 15.8 15.9 15.57 15.71 2026-04-13 16.3 16.54 16.17 16.31
2026-06-15 16.0 16.08 15.73 15.8 2026-04-10 16.8 16.8 16.42 16.47
2026-06-12 16.1 16.18 15.95 16.05 2026-04-09 16.5 16.77 16.44 16.71
2026-06-11 15.7 16.13 15.66 15.98 2026-04-08 16.3 16.64 16.2 16.63
2026-06-10 15.9 15.93 15.62 15.62 2026-04-07 16.6 16.64 16.19 16.2
2026-06-09 15.7 15.88 15.52 15.87 2026-04-06 16.6 16.75 16.51 16.67
2026-06-08 16.1 16.13 15.6 15.61 2026-04-02 16.9 17.02 16.6 16.74
2026-06-05 16.0 16.24 15.95 16.09 2026-04-01 17.2 17.48 17.1 17.34
2026-06-04 15.7 15.95 15.6 15.9 2026-03-31 16.9 17.17 16.83 17.04
2026-06-03 15.3 15.47 15.26 15.37 2026-03-30 16.8 16.87 16.6 16.78
2026-06-02 15.4 15.61 15.22 15.3 2026-03-27 17.3 17.3 16.92 16.97

Bristol-Myers Squibb Co (BMY) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.